FRONTEO to Provide AI Process Outsourcing Services
Nov 29, 2016 13:01 pm UTC| Business
Aims to accelerate the introduction and implementation of its AI applications for customers when dealing with massive amounts of data Builds an integrated system spanning AI-related services from products and trainings...
Nov 29, 2016 13:01 pm UTC| Business
Phoenix, Nov. 29, 2016 -- Jean Ekobo, CEO of BioNovelus Inc. recently attended the ‘Sintercafe - International Coffee Week,’ the largest coffee convention in Central America. This year, Sintercafé celebrated its 30th...
Nov 29, 2016 13:01 pm UTC| Business
Phoenix, Nov. 29, 2016 -- Jean Ekobo, CEO of BioNovelus Inc. recently attended the ‘Sintercafe - International Coffee Week,’ the largest coffee convention in Central America. This year, Sintercafé celebrated its 30th...
Strongbridge Biopharma plc Announces Promotion of Fredric Cohen, M.D., to Chief Medical Officer
Nov 29, 2016 13:01 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Nov. 29, 2016 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global biopharmaceutical company focused on the development and commercialization of novel therapies for rare diseases,...
Strongbridge Biopharma plc Announces Promotion of Fredric Cohen, M.D., to Chief Medical Officer
Nov 29, 2016 13:01 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Nov. 29, 2016 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global biopharmaceutical company focused on the development and commercialization of novel therapies for rare diseases,...
Nov 29, 2016 13:01 pm UTC| Business
CAMBRIDGE, Mass., Nov. 29, 2016 -- Momenta Pharmaceuticals,Inc. (Nasdaq:MNTA) today announced that the confirmatory Phase 3 clinical study of M923, a biosimilar HUMIRA® (adalimumab) candidate developed in collaboration...
Nov 29, 2016 13:01 pm UTC| Business
CAMBRIDGE, Mass., Nov. 29, 2016 -- Momenta Pharmaceuticals,Inc. (Nasdaq:MNTA) today announced that the confirmatory Phase 3 clinical study of M923, a biosimilar HUMIRA® (adalimumab) candidate developed in collaboration...